Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atul Pande Insider Profile
4 Followers
Atul Pande, Director at Sio Gene Therapies, holds 106.66K shares in Immunovant (Ticker: IMVT), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX), holds 33.37K shares in Sio Gene Therapies (Ticker: SIOX).
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
+47.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Atul Pande holds in companies
Most Profitable Insider Trade
The most profitable trade made by Atul Pande
Atul Pande's Trading History
Sio Gene Therapies
Nov 25, 2020
―
Informative Buy
23.30K
$15.95K
Karuna Therapeutics
Mar 18, 2024
―
Uninformative Sell
326.70K
$0.00
Immunovant
Dec 04, 2024
Director
Uninformative Sell
221.19K
$2.76M
List of latest transactions for each holding click on a transaction to see Atul Pande's performance on stock
You May Also Like
Atul Pande insider profile FAQ
What is the percentage of profitable transactions made by Atul Pande?
The percentage of profitable transactions made by Atul Pande is 33%.
What is the average return per transaction made by Atul Pande?
The average return per transaction made by Atul Pande is 47.80%.
What stocks does Atul Pande hold?
Atul Pande holds: SIOX, KRTX, IMVT stocks.
What was Atul Pande’s latest transaction?
Atul Pande latest transaction was an Uninformative Sell of $221.19K.
What was Atul Pande's most profitable transaction?
Atul Pande’s most profitable transaction was an Informative Buy of IMVT stock on October 4, 2022. The return on the trade was 316.20%.
What is Atul Pande's role in Sio Gene Therapies?
Atul Pande's role in Sio Gene Therapies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.